Evidence mapPaperPMID 24196409Full record

ArticleChemical communications (Cambridge, England)2013

Advances in nucleophilic phosphine catalysis of alkenes, allenes, alkynes, and MBHADs.

Yi Chiao Fan, Ohyun Kwon

Abstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
21.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 419 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Chiral Isochalcogenourea-Catalysed Enantioselective (4+2) Cycloadditions of Allenoates.Angewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2024
    Article
  8. Article
  9. Article
  10. Nucleophilic Phosphine Catalysis: The Untold Story.Asian journal of organic chemistry · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Validating the Biphilic Hypothesis of Nontrigonal Phosphorus(III) Compounds.Angewandte Chemie (International ed. in English) · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yi Chiao FanDepartment of Chemistry and Biochemistry, University of California, Los Angeles, California 90095-1569, USA. Ohyun@chem.ucla.edu.
Ohyun Kwon
University of California, Los Angeles · US

Funding

Phosphine-Catalyzed Annulations and their ApplicationsR01GM071779 · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2025 to 2025
$358k
NIGMS NIH HHS GM071779NIGMS NIH HHS R01 GM071779
6 · The paper itself

Abstract

In nucleophilic phosphine catalysis, tertiary phosphines undergo conjugate additions to activated carbon-carbon multiple bonds to form β-phosphonium enolates, β-phosphonium dienolates, β-phosphonium enoates, and vinyl phosphonium ylides as intermediates. When these reactive zwitterionic species react with nucleophiles and electrophiles, they may generate carbo- and heterocycles with multifarious molecular architectures. This article describes the reactivities of these phosphonium zwitterions, the applications of phosphine catalysis in the syntheses of biologically active compounds and natural products, and recent developments in the enantioselective phosphine catalysis.

Indexed as

AlkadienesAlkenesAlkynesCatalysisPhosphinesAlkadienesAlkenesAlkynesphosphinePhosphinespropadiene

Identifiers

PMID24196409
PMCPMC3896345
OpenAlexW2053725113

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.